ライフサイエンスコーパス: female patient

1 nt 1 or more surgical procedures (55.1% were female patients).

2 d deviation]; 98 [63.2%] male and 57 [36.8%] female patients).

3 .3 years (range, 12-54 years; 75 male and 30 female patients).

4 d 0.28 +/- 0.05 times the thoracic width for female patients.

5 expression response was similar in male and female patients.

6 rstand differences in responses in males and female patients.

7 th lower concentrations for male compared to female patients.

8 g polypeptide has been reported with PTSD in female patients.

9 milial risk or heritability between male and female patients.

10 la to the posterior thalamus in male but not female patients.

11 There were 17 male and 13 female patients.

12 ts, 5.3% black male patients, and 3.8% black female patients.

13 Similar results were obtained for female patients.

14 ia patients as compared to the 32-depressive female patients.

15 There were 9 male and 6 female patients.

16 te and developmental defects in heterozygous female patients.

17 no statistically significant association in female patients.

18 may be preferred over surgery for high-risk female patients.

19 ose under 40 at the time of treatment and in female patients.

20 and, for lung cancer and colorectal cancer, female patients.

21 after SSRI exposure was seen in male but not female patients.

22 cular OAL was more commonly found in elderly female patients.

23 There were 13 male and 18 female patients.

24 , 45-94 years), and there were 10 male and 8 female patients.

25 ur with an incidence of 10.3% in nonpregnant female patients.

26 s, less pain, and shorter recovery times for female patients.

27 on sexual and urinary functions in male and female patients.

28 ancer of 1.6% for male patients and 1.9% for female patients.

29 There were 4 male patients and 6 female patients.

30 ed greater mortality reduction compared with female patients.

31 time risk was found to be higher in younger, female patients.

32 ed higher activity in the left amygdala than female patients.

33 are often hampered by the enrollment of few female patients.

34 ontal cortices compared with healthy men and female patients.

35 ignificantly more important among colorectal female patients.

36 Costs are about 50% higher in fertile-age female patients.

37 ns, 1-year adjusted survival was superior in female patients.

38 ars old than >/=10 years old (odds ratio for female patients, 0.67; 95% CI, 0.58-0.78; odds ratio for

39 as reported by nine partners (10.3%) and two female patients (11.8%), and three patients (2.0%) repor

40 male patients (chi(2) trend 39.6; p<0.0001), female patients (13.9; p=0.0002), and both sexes combine

41 with large differences seen between male and female patients (15% lower for women in same age group).

42 of chromosome X was detected exclusively in female patients (17.1%).

43 n age of 26.7 years [range, 16-53 years]; 18 female patients (19 hips) with a mean age of 28.9 years

44 of whom were female (29%) (ratio of male to female patients, 2.4:1).

45 s (mean [SD] age, 62.8 [13.4] years; 12 were female patients), 20 eyes without DR from 11 diabetic pa

46 A histopathologic data set (n = 368; 144 female patients, 224 male patients) was used to validate

47 KRAS patients were observed between male and female patients (32.5% versus 34.8%, respectively; p = 0

48 k female patients (44.1%), followed by white female patients (38.4%), black male patients (36.4%), an

49 om January 1, 1998, to December 31, 2012, of female patients 40 to 99 years of age with a clinical di

50 d rehospitalization were highest among black female patients (44.1%), followed by white female patien

51 younger (58 v 68 years, respectively), fewer female patients (46% v 65%, respectively), and patients

52 , 4.1]; 1327 non-Hispanic white [76.0%]; 867 female patients [49.7%]), and 272 had type 2 (mean age,

53 were 66.6% white male patients, 24.3% white female patients, 5.3% black male patients, and 3.8% blac

54 D] patient age, 65.74 [12.32] years; 5975798 female patients 56.60%]) for major noncardiac surgery, p

55 SD, 3.5]; 72 non-Hispanic white [26.5%]; 181 female patients [66.5%]).

56 The molecular profiles for 99 patients (30 female patients, 69 male patients) were identified from

57 years old with Crohn's disease were 0.35 for female patients (95% CI, 0.16-0.78) and 0.59 for male pa

58 rs old with ulcerative colitis were 0.88 for female patients (95% CI, 0.47-1.63) and 0.42 for male pa

59 ulmonary benign metastasizing leiomyoma in a female patient admitted to our hospital with suspicion o

60 We describe a unique case of a 23-yr-old female patient affected by a homozygous loss of function

61 ratio, 0.29; 95% CI, 0.11-0.77; p < 0.01) in female patients after dexamethasone administration.

62 We recruited female patients (age 16 years or older) from 32 centres

63 Twelve female patients (age range, 19-54 years; mean age, 41.2

64 with thalamic electrodes (nine male and one female patients, age: 34-74 years).

65 c or subthalamic electrodes (13 male and two female patients, age: 50-77 years) and 10 patients with

66 Thirteen male and four female patients aged 17-56 completed the study protocol.

67 Male and female patients aged 18 through 55 years (18-60 years fo

68 entified 330 pregnant and 10 562 nonpregnant female patients aged 18 to 44 years with HS in Get With

69 en-label, non-inferiority trial, we enrolled female patients (aged 11-18 years) with anorexia nervosa

70 l, dose-escalation study in the UK, male and female patients (aged 18 years or older) with Friedreich

71 our analysis made up of 70.3% male and 29.7% female patients, an approximately 20% lower risk for the

72 There were 2 white female patients and 1 African American male patient.

73 Three female patients and 1 male patient underwent iris tumor

74 A total of 22 eyes from 16 female patients and 1 male patient with foveomacular sch

75 There were 12, 7, and 8 female patients and 13, 6, and 6 male patients in the iS

76 Both male and female patients and controls were tested.

77 otentially lethal complication, is higher in female patients and in older adults with untreated defec

78 In female patients and mice the above observations were not

79 situations as safe, uncertain, or risky, but female patients and mothers rated fewer situations as sa

80 w-up period of 9.3 years, 227 women (9.9% of female patients) and 129 men (20% of male patients) with

81 DTI in 69 patients with mTBI (47 male and 22 female patients) and 21 control subjects (10 male and 11

82 ; age range, 10-22 years; nine male and four female patients) and one additional comparative patient

83 ts (mean [SD] age, 58.8 [10.1] years; 5 were female patients), and 16 eyes from 12 healthy age-matche

84 y-two patients had XLP (9.7%; 10 male and 12 female patients), and 9 patients (4.0%) had elevated ePP

85 6.3 years; 67.7% of eyes (180/266) were from female patients, and 95.5% (254/266) were from white pat

86 tient and outpatient settings, from male and female patients, and across age groups from 18 to 89 yea

87 male patients and 25.5 years (25.2-25.8) for female patients, and for external-cause deaths was 40.2

88 Female patients appear to be less aroused through reject

89 Young female patients appear to have the greatest benefit from

90 nia compared with healthy controls, and that female patients are at greater risk than male patients.

91 al, with written informed consent, recruited female patients at elevated risk for breast cancer (eg,

92 However, in female patients, beneficial effects on the occurrence of

93 All TV NOTES procedures performed in female patients between 18 and 65 years of age were incl

94 sterior middle cingulate cortex was found in female patients but negative connectivity was found in m

95 d with an increase in all-cause mortality in female patients, but not in male patients with Raynaud p

96 l cortex (PFC) and dorsal posterior INS; (2) female patients compared with male patients had greater

97 dividual subjects reported benefits; e.g., a female patient could stand up from sitting on the floor

98 uspected in consanguineous families and when female patients develop renal failure.

99 Female patients diagnosed as having stage IV breast canc

100 ulcer osteomyelitis, whereas only 28 (4%) of female patients did (OR 2.21, 95% CI 1.39-3.59).

101 and the basal metabolic rate (BMR) in obese female patients during the initial 3 y after an RYGB.

102 l analysis of data obtained on 3121 male and female patients evaluated at the Cooper Clinic in Dallas

103 A 26-year-old female patient exhibited symptoms associated with egg al

104 There was also a relationship with female patient gender (P = 0.042).

105 special features of HAE-C1-INH treatment in female patients, genetic counseling, infertility, aborti

106 ion overall and particularly among black and female patients, given their high prevalence of post-MI

107 ods (odds ratio=0.81, 95% CI=0.78-0.85), and female patients had 14% lower odds of substance-related

108 ion (odds ratio=0.65, 95% CI=0.64-0.67), and female patients had 31% lower odds of concurrent substan

109 Compared with male patients, female patients had a 19% significantly lower risk for t

110 th months when not receiving medication, and female patients had a 42% (odds ratio, 0.58; 95% CI, 0.5

111 Female patients had a higher likelihood of complete clin

112 cidence rate was found by sex (P = .63), but female patients had a higher prevalence (P = .008).

113 Despite the male predominance, female patients had a risk profile superimposable to tha

114 Female patients had higher body fat (P = .002) and lower

115 (1031+/-74 versus 954+/-32 ms, P<0.001) and female patients had higher RV T1 compared with males (10

116 this region: (1) male patients compared with female patients had increased positive connectivity of t

117 ality risk scores (11.9 vs. 11.6; p = 0.05), female patients had lower prevalence of coronary artery

118 In addition, female patients had significantly lower fractional aniso

119 Tumors from female patients have a higher frequency of KDM6A mutatio

120 Female patients have a higher prevalence of vasomotor dy

121 The homozygous female patient in family 1 displayed a severe phenotype.

122 is of molecular differences between male and female patients in 13 cancer types of The Cancer Genome

123 There were 6 male and 3 female patients in Group 1, and the average age of patie

124 There were 5 male and 2 female patients in Group 2 and the average age of patien

125 and sex reversal, such as XY phenotypically female patients in humans.

126 Of 1112 female patients in the registry, 669 (60.2%) had undergo

127 nd race, male patients had higher rates than female patients (incidence rate ratio [IRR], 1.65; 95% C

128 Of 108 patients (including eight female patients) included in the study, 23 (21%) had ear

129 tality was potentially more pronounced among female patients (interaction p = 0.05), but did not diff

130 , controlled trial conducted specifically in female patients is necessary to properly study differenc

131 1 diabetes was slightly raised, whereas for female patients it was 50% higher.

132 10(9)/L, and anemia (hemoglobin < 10 g/dL in female patients, < 11g/dL in male patients).

133 Insight into the survival advantage of female patients may advance the molecular understanding

134 Among the 133 female patients (mean [SD] age, 37.4 [7.5] years), worse

135 ere reviewed in 499 (53%) male and 440 (47%) female patients (mean age, 10 years).

136 A total of 33 SLE predominantly female patients (mean age, 40+/-9 years) underwent cardi

137 In 59 male and 33 female patients (mean age, 66 years) undergoing hemineph

138 n age, 66.1 years; range 36-83 years) and 40 female patients (mean age, 66.8 years; age range, 36-90

139 patients (5093 [47.4%] male and 5648 [52.6%] female patients; mean [SD] age, 53.0 [23.0] years).

140 nation for clinical purposes (93 male and 63 female patients; mean age +/- standard deviation, 59.8 y

141 ncluded in this study (25 male patients, two female patients; mean age, 32.6 years).

142 of whom 78 had analyzable data (57 male, 21 female patients; mean age, 66+/-9 years).

143 Fifty-four patients (42 male and 12 female patients; mean age, 70.9 years +/- 9.3 [standard

144 ind placebo-controlled crossover trial of 14 female patients (median age 52 [30-69] years) with proct

145 February to December 2009 were reviewed; 147 female patients (median age, 48 years; range, 26-86 year

146 o or trivial mitral regurgitation, and 16 (6 female patients; median age: 40 years) MVP patients with

147 Thirty-six (27 female patients; median age: 44 years) arrhythmic MVP pa

148 raphy was used to record C nociceptors of 30 female patients meeting criteria for fibromyalgia and co

149 rom adrenalectomy, with younger patients and female patients more likely to have a favourable surgica

150 1-year postdischarge angina, with black and female patients more likely to have angina and to be reh

151 Female patients (n = 162) with FTV and RFS were included

152 All female patients (n=16) had crazy-paving, while 13 out of

153 dence of pulmonary hypertension is higher in female patients, numerous experimental studies have demo

154 ng of patients within physicians, found that female patients (odds ratio [OR] = 2.58; 95% CI, 1.53-4.

155 Participants were 8 female patients of white race/ethnicity with highly acti

156 A female patient on quinidine for atrial fibrillation who

157 er risk for osteoporosis and osteopenia than female patients (OR 0.45; 95% CI 0.29 to 0.68).

158 for trauma male patient and 9.1% for trauma female patient (p = 0.065) and 22.9% for nontrauma male

159 The ED50 value was 65% lower in female patients (P = .0001) and 71% lower in all asthmat

160 trauma male patients and 20.6% for nontrauma female patients (p = 0.40).

161 sequence of decreased miRNA-96 expression in female patient PASMCs, and this may contribute to the de

162 larger burden of olfactory deficit and older female patients performing better on olfactory tests.

163 A 39 years old caucasian female patient presented at the Department of Neurology

164 This female patient presented in the second decade of life wi

165 18 year old female patient presented to the surgery OPD with complai

166 A 28-year-old female patient presented with complaints of severe abdom

167 A 40-year-old female patient presented with history of headache since

168 The mean (SD) age of the 5 female patients presented in this case series was 35.2 (

169 Case Report: A middle-aged female patient presenting with a history of multiple chr

170 report the case of a 66-year-old anal cancer female patient presenting with an asymptomatic sub-hepat

171 Median age was 32 years, with female patients presenting at a younger age than male pa

172 The paper discusses three cases of female patients presenting typical pulmonary complicatio

173 Among female patients, procedural mortality trended lower with

174 A 45-year-old female patient received docetaxel treatment after resect

175 ps were similar demographically, except more female patients received SC-PEG2500.

176 ated to be as high as 7.9% for a 20-year-old female patient receiving a PET/CT scan every 6 months fo

177 cquisitions were performed in 54 consecutive female patients referred for 3-T magnetic resonance (MR)

178 Female patients referred to the British Columbia Cancer

179 tained in those patients (including male and female patients separately) with high versus low MR imag

180 evere atypical psychiatric symptoms in young female patients should raise the index of suspicion for

181 Female patients showed significantly lower volumes of ne

182 Female patients, soft CLs, and extended duration of wear

183 ly people (>/=85 years), and were higher for female patients than for male patients of all ages.

184 ety disorder with higher prevalence rates in female patients than in male patients (2.5:1).

185 nemia presented 2.5 times more frequently in female patients than in male patients.

186 In female patients the change was -0.69D (P < 0.01), while

187 of existing cardiac assessments in diabetic female patients to detect myocardial deformation, cardia

188 NASH FibroSure may be used, especially among female patients, to help monitor for risk of worsening f

189 ng were shown in male BPD patients, while in female patients trait anger positively modulated dorsola

190 Between 2012 and 2014, 207 female patients undergoing surgery for potential or know

191 Female patients undergoing TAVR had a different risk pro

192 tients (mean age, 49 years; 212 male and 188 female patients) undergoing lumbar spine CT for low back

193 Female patients, unlike male patients, with high volumes

194 A 68-year-old female patient was admitted to the Internal Diseases Cli

195 A 29-year-old female patient was referred to our department by her oph

196 We found that the AAO of female patients was approximately 5 months earlier than

197 or the combined cardiovascular end points in female patients was observed despite treatment with card

198 The overall reported incidence of ZVD among female patients was twice that in male patients.

199 Diabetic female patients were characterized by a higher risk for

200 One hundred forty-three consecutive female patients were examined by using an image-processi

201 Female patients were more compliant than male patients w

202 Female patients were more reactive and secretive than ma

203 Female patients were more sensitive to acetylcholine wit

204 Compared with male patients, female patients were older, with a lower prevalence of c

205 Female patients were over-represented in the H tumor gro

206 Two male and three female patients were recruited in this study.

207 ve CVR examinations from 294 patients (51.8% female patients) were studied.

208 ancer of 0.9% for male patients and 1.3% for female patients, whereas an annual PET/CT each year for

209 A female patient who died in 2012 received a diagnosis of

210 We presented a 60-year-old female patient who had both hyperdense middle cerebral a

211 We present a female patient who noted decreased vision after docetaxe

212 We report the case of an adult female patient who presented for a deceased donor kidney

213 CC15 is the most cost-effective strategy for female patients who are between 40 and 60 years of age a

214 This study compares these 2 techniques in female patients who are in need of an elective cholecyst

215 CC10 is the most cost-effective strategy for female patients who are younger than 40 years, and CC15

216 There were 4127 female patients who initiated quadrivalent HPV vaccinati

217 The percentage of female patients who underwent bariatric surgery decrease

218 Participants were female patients who were diagnosed as having breast canc

219 locate resources to the increasing number of female patients who will present to healthcare providers

220 the case of an otherwise healthy adolescent female patient, who, despite aggressive management, succ

221 We present the case of a 21-year-old female patient with a 5-year history of a solitary, slow

222 We report the case of a 64-year-old female patient with a history of long-term NSAID use, wh

223 rom a PEODDN lesion of a primary school-aged female patient with bands of hyperkeratotic-affected ski

224 We present a long term follow-up of a young female patient with choroidal infarction, primary open a

225 CASE REPORT: We present a 48-year-old female patient with complaints of abdominal pain and jau

226 76-year old obese (BMI 32 kg/m(2)), female patient with history of hypertension, stable coro

227 ift mutation was discovered in a 10-year-old female patient with LQTS with a QTc of 500 milliseconds

228 e report on a clinical case of a 16-year-old female patient with massive hematemesis, who was success

229 We report a female patient with MCAD-deficiency in whom at the age o

230 An unvaccinated, young, female patient with measles confirmed by direct epidemio

231 re a new hemoglobin alpha chain variant in a female patient with mild anemia, whose father also carri

232 We report a 29 year old female patient with neck tumor suspected to be a sarcoma

233 e-blind group design, 40 nonmedicated, adult female patients with a current DSM-IV diagnosis of borde

234 essel occlusion and were mostly diagnosed in female patients with a fair to good interobserver agreem

235 up consisted of 114 patients (57 male and 57 female patients with a mean age of 26.1 and 25.1 years,

236 The obese group consisted of 72 female patients with a mean age of 37.27 +/- 1.18 years.

237 The study population included 13 male and 6 female patients with a mean age of 55 years.

238 We report 3 female patients with a median age of 39 years (range, 26

239 ere acquired from adolescent and young adult female patients with acute AN (n = 40), recovered patien

240 d hazard ratio, 1.47; 95% CI, 1.32-1.63) and female patients with ADHD (1.45; 1.24-1.71) had an incre

241 open-label parallel-group study in male and female patients with alcohol-related cirrhosis and porta

242 arning and value-based decision making in 36 female patients with AN and 36 age-matched healthy volun

243 up consisted of 150 patients (76 male and 74 female patients with an average age of 41.2 and 41.5 yea

244 Sixty-one adolescent female patients with anorexia nervosa and 45 age- and se

245 Beginning in 1987, 246 treatment-seeking female patients with anorexia nervosa or bulimia nervosa

246 hods The cohort consisted of 910 consecutive female patients with BC treated with radiotherapy (RT) a

247 ith a life-time history of poly drug use and female patients with borderline personality disorder are

248 rial/A prospective study was conducted in 28 female patients with breast cancer and with at least one

249 TIENTS AND METHODS The study cohort included female patients with breast cancer in the Stockholm heal

250 As more young female patients with cancer survive their primary diseas

251 We conducted a prospective study of female patients with CD (age, 16-51 y), identified from

252 akinra versus placebo on fatigue severity in female patients with CFS.

253 ic resonance imaging, we found that male and female patients with chronic neuropathic orofacial pain

254 Observations: Three eyes from 2 young female patients with classic features of AMN are present

255 Female patients with codes for delivery from the Interna

256 lassification of female healthy smokers from female patients with COPD with 78% predictive power.

257 The HRs for 42-day and 1-year mortality in female patients with DM and CKD were 4.03 (95%CI, 1.40-1

258 analyses to compare the hazard of death for female patients with early-stage invasive ductal carcino

259 and CT may be variously involved in male and female patients with FD cardiomyopathy, affecting CT fun

260 factor analysis suggested that cell death in female patients with GBM is associated with MYC, while t

261 We identified 32 female patients with genital chronic GVHD (cGVHD) who un

262 A consensus for the management of female patients with HAE-C1-INH is presented.

263 anagement of gynecologic/obstetric events in female patients with HAE-C1-INH.

264 We enrolled female patients with HER2-overexpressing metastatic brea

265 anagement of gynecologic/obstetric events in female patients with hereditary angioedema caused by C1

266 This prospective clinical study compared 96 female patients with iron-deficiency anemia and 60 healt

267 Female patients with LHON had a significantly greater ri

268 M1, GRM4, GRM5 and GRM7 were detected in the female patients with MDD.

269 There were 10 male and 22 female patients with mean age of 41.8 +/- 8.6 years.

270 Between 2001 and 2011, 215 female patients with MRKH syndrome attended clinics, and

271 s of the CNS of both female SJL EAE mice and female patients with MS compared with their male counter

272 Female patients with MS have higher survival disadvantag

273 idence interval: 0.375, 0.476) compared with female patients with mTBI and control subjects (P < .05)

274 Female patients with MTBI had lower digit span scores th

275 ay suggest a worse working memory outcome in female patients with MTBI.

276 CT symptom scores (P = .33) between male and female patients with mTBI.

277 We report on 7 female patients with neurologic symptoms and signs inclu

278 Female patients with NF1-associated optic glioma were tw

279 more, serum miR-223 levels were decreased in female patients with PAH associated with congenital hear

280 /-) PASMCs from female mice and hPASMCs from female patients with PAH; this was associated with incre

281 However, in 1968, Zollinger et al reported 2 female patients with pancreatic neuroendocrine tumors, W

282 Twelve female patients with primary Sjogren's syndrome were adm

283 Compared with males, female patients with psoriasis were 1.47 times more like

284 Cluster 3 patients were obese female patients with reversible airflow obstruction who

285 Male and female patients with severe obesity had a 2.5- to 4-fold

286 myalgia and compared with recordings from 17 female patients with small-fiber neuropathy and 9 female

287 responses to mental stress between male and female patients with stable IHD.

288 intervention), compared with NC (control) in female patients with symptomatic cholecystolithiasis.

289 Compared to males, female patients with T2DM had a higher body mass index (

290 vestigating gonadal dysgenesis in phenotypic female patients with the 46, XY karyotype.

291 luster T4 is predominantly composed of obese female patients with uncontrolled severe asthma with inc

292 The study population comprised 30 female patients with VLS.

293 gs are effective alternatives to surgery for female patients with vulval intraepithelial neoplasia af

294 d imiquimod--as an alternative to surgery in female patients with vulval intraepithelial neoplasia.

295 Marked clinical variability was seen in female patients with XLP owing to random X-chromosomal i

296 ntions seem to be most important for (mainly female) patients with difficult interpersonal relationsh

297 his retrospective analysis of 36 consecutive female patients, with unilateral unifocal primary breast

298 e melanoma patients have worse survival than female patients, yet the detailed mechanisms for this ge

299 nited States that disproportionately affects female patients, young adults, and African American and

300 Between Jan 1, 1996, and June 30, 2012, 410 female patients younger than 18 years at diagnosis were